Nearly half of the children receiving intranasal midazolam for laceration repair in the emergency department (ED) exhibited extreme procedural anxiety. Younger age, reduced sociability, and extremity ...
Proximagen announced promising data from the pivotal Phase 3 trial of USL261 (intranasal midazolam) for the rescue treatment of seizure clusters. The primary efficacy endpoint was treatment success, ...
Holsti and colleagues state that seizures lasting more than 5 minutes in the out- of-hospital setting are often treated by the patient's family. In the United States, rectal diazepam is the most ...
Objective: To evaluate the feasibility of a sedation protocol based on Lidocaine spray and Intranasal Midazolam (INM) administered by Mucosal Atomizer Device (MAD) in uncooperative children undergoing ...
CAMBRIDGE, England, April 26, 2017 /PRNewswire/ -- Proximagen Limited (Proximagen) today announced that its pivotal Phase 3 trial of intranasal midazolam (USL261) for the rescue treatment of seizure ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Intranasal ...
Débora P. H. Schaffer, Nayone L. L. C. de Araújo, Ana Cláudia S. Raposo, Emanoel F. Martins Filho, João Victor R. Vieira and Arianne P. Oriá Safe and effective sedation protocols are important for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results